Cargando…
Spontaneous psoas hematoma in a case of acute myocardial infarction following streptokinase infusion
INTRODUCTION: Cardiovascular disorders are the major cause of mortality and morbidity globally as well as in India. In India, where resources are limited and majority of patients pay out of their own pocket, thrombolysis is still done for majority of STEMI cases. CASE SCENARIO: A 48-year-old male pa...
Autores principales: | Abhishek, B. Sunil, Vijay, Sai C., Avanthi, V., Kumar, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067465/ https://www.ncbi.nlm.nih.gov/pubmed/27751282 http://dx.doi.org/10.1016/j.ihj.2015.09.031 |
Ejemplares similares
-
The chronergy of recombinant streptokinase thrombolysis in acute myocardial infarction
por: WANG, ZHONG-MING, et al.
Publicado: (2013) -
Primary angioplasty versus streptokinase in elderly patients with acute myocardial infarction
por: Leite, PF, et al.
Publicado: (2001) -
Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen
por: Bendary, Ahmed, et al.
Publicado: (2017) -
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
por: Betancourt, Blas Y, et al.
Publicado: (2005) -
Leucocytoclastic vasculitis: A complication after streptokinase therapy for acute myocardial infarction
por: Makkar, Manisha, et al.
Publicado: (2013)